SuPAR: a potential predictive biomarker for acute kidney injury
- PMID: 32269303
- DOI: 10.1038/s41581-020-0276-7
SuPAR: a potential predictive biomarker for acute kidney injury
Comment on
-
Soluble Urokinase Receptor and Acute Kidney Injury.N Engl J Med. 2020 Jan 30;382(5):416-426. doi: 10.1056/NEJMoa1911481. N Engl J Med. 2020. PMID: 31995687 Free PMC article.
References
-
- Hayek, S. S. et al. Soluble urokinase receptor and acute kidney injury. N. Engl. J. Med. 382, 416–426 (2020). - DOI
-
- American Society of Nephrology Renal Research Report. J. Am. Soc. Nephrol. 16, 1886–1903 (2005).
-
- Griffin, B. R., Gist, K. M. & Faubel, S. Current status of novel biomarkers for the diagnosis of acute kidney injury: a historical perspective. J. Intensive Care Med. 35, 415–424 (2020). - DOI
-
- Zarbock, A. et al. Effect of early versus delayed initiation of renal replacement therapy on mortality in critically ill patients with acute kidney injury: the ELAIN Randomized Clinical Trial. JAMA 315, 2190–2199 (2016). - DOI
-
- Endre, Z. H. et al. Early intervention with erythropoietin does not affect the outcome of acute kidney injury (the EARLYARF trial). Kidney Int. 77, 1020–1030 (2010). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
